Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Casdin Capital
Work at Casdin Capital?
Add yourself to this profile
0
Casdin Capital
Casdin Capital, LLC is an investment firm focused on disruptive businesses in the life sciences and healthcare industry.
Edit Profile
casdincapital.com
B2c
More info
Elsewhere
Alexa global traffic share
Twitter followers
Overview
Investments
13
Portfolio
Add info
All markets
Biotechnology (8)
Health Care (5)
Health And Wellness (1)
Insurance (1)
Big Data (1)
Life Sciences (1)
Clinical Trials (1)
Search (1)
All countries
United States (11)
All company sizes
11-50 (4)
51-200 (6)
201-1000 (1)
23andMe
Search +1
Total funding
$228.8M in
9 rounds
from 24 investors
By Casdin Capital
$115M Series E in Jul, 2015
Syros Pharmaceuticals
Biotechnology
Total funding
$123M in
3 rounds
from 13 investors
By Casdin Capital
$40M Series C in Jan, 2016
Flatiron Health
Health and Wellness +1
Total funding
$314.4M in
4 rounds
from 17 investors
By Casdin Capital
$175M Series C in Jan, 2016
Editas Medicine
Biotechnology
Total funding
$257M in
3 rounds
from 17 investors
By Casdin Capital
$120M Series B in Aug, 2015
Clover Health
Health Care +1
Total funding
$295M in
3 rounds
from 19 investors
By Casdin Capital
$160M Series C in May, 2016
Foundation Medicine
United States
Total funding
$76M in
2 rounds
from 10 investors
By Casdin Capital
$42.5M Series B in Sep, 2012
Invitae
Health Care +1
Total funding
$160M in
2 rounds
from 19 investors
By Casdin Capital
$120M Series F in Oct, 2014
Blueprint Medicines
Health Care +1
Total funding
$240M in
4 rounds
from 16 investors
By Casdin Capital
$25M Series B in Jan, 2014
Omicia
Big Data +3
Total funding
$29.8M in
2 rounds
from 12 investors
By Casdin Capital
$6.8M Series A in Jan, 2014
Exit
Spiral Genetics
, Jan 23, 2017
MyoKardia
Biotechnology
Total funding
$94M in
3 rounds
from 7 investors
By Casdin Capital
$46M Series B in Apr, 2015
Jounce Therapeutics
Biotechnology
Total funding
$158M in
2 rounds
from 9 investors
By Casdin Capital
$56M Series B in Apr, 2015
Magenta Therapeutics
Biotechnology
Total funding
$98.5M in
2 rounds
from 11 investors
By Casdin Capital
$50M Series B in May, 2017
Want to see the complete list?
Go Pro!
